Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitus
Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitus
复制标题
DOI:
10.1016/j.diabres.2016.04.027
复制
发表时间:
2016-06-01
影响因子:
5.1
通讯作者:
Sugimoto, Toshitsugu
中科院分区:
文献类型:
--
作者:
Tanaka, Sayuri;Kanazawa, Ippei;Sugimoto, Toshitsugu
Objective: The relationship between serum DPP-4 level and visceral fat mass is still unclear in type 2 diabetes mellitus (T2DM). This study thus aimed to examine the association of visceral fat accumulation and metabolic syndrome with serum DPP-4 levels in T2DM.Methods: Visceral and subcutaneous fat areas were evaluated by performing computed tomography scan in 135 men with T2DM, who had never taken DPP-4 inhibitors or GLP-1 receptor agonists. We investigated the association between serum DPP-4 levels and visceral fat area as well as the presence of metabolic syndrome.Results: Multiple regression analysis adjusted for age, duration of T2DM, body mass index, serum creatinine, and HbA1c showed that serum DPP-4 levels were positively associated with visceral fat area (beta = 0.25, p = 0.04), but not subcutaneous fat area (beta = -0.18, p = 0.13). In logistic regression analyses adjusted for the confounding factors described above, serum DPP-4 levels were positively associated with visceral fat obesity and metabolic syndrome [odds ratio (OR) = 1.63, 95% confidence interval (CI) = 1.00-2.66 per standard deviation (SD) increase, p = 0.04; OR = 1.77, 95% CI = 1.09-2.88 per SD increase, p = 0.02, respectively].Conclusions: The present study showed that serum DPP-4 level was positively and specifically associated with accumulation of visceral fat and the presence of metabolic syndrome in men with T2DM. (C) 2016 Elsevier Ireland Ltd. All rights reserved.